Category: ‘Clinical Trials and Studies’

Elon Musk’s Neuralink to Start Human Trial of Brain Implant

Posted on September 20th, 2023

Billionaire entrepreneur Elon Musk’s brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human trial of its brain implant for paralysis patients.

Those with paralysis due to cervical spinal cord injury or amyotrophic lateral sclerosis may qualify for the study, it said, but did not reveal how many participants would be enrolled in the trial, which will take about six years to complete.

New Trial Gives Hope To People With Spinal Cord Injuries In Australia

Posted on April 13th, 2023

Doctors say they’re on the cusp of offering the chance to return function to people living with spinal cord injuries, and the treatment will soon be available in Australia.

Orthocell Delivers Outstanding Results in Remplir™ Nerve Regeneration Trial

Posted on June 7th, 2022

Keio University Uses iPS Cells in First Treatment of Spinal Cord Injury

Posted on January 15th, 2022

Keio University in Tokyo said Friday it has started the world’s first clinical test using induced pluripotent stem cells, or iPS cells, to treat patients with spinal cord injuries.

In the study commenced in December, the university will eventually transplant cells derived from iPS cells to four patients who between two to four weeks earlier lost motor and sensory function after sustaining injuries when playing sport or in traffic accidents.

Israeli Biotech Company, Matricelf, Paves a New Way in Healing Injured Spinal Cords

Posted on January 12th, 2022

The company successfully used human implants for replacing the injured spinal cord of a living pig, thereby simulating the anticipated surgical procedure in humans.

Spinal cord injuries are notoriously difficult to operate on, but an Israeli biotech company has entered a new road on the way to a cure using pigs.

« Older Entries